Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Srivastava, Shashikant
222  Ergebnisse:
Personensuche X
?
1

Ertapenem's therapeutic potential for Mycobacterium avium l..:

Deshpande, Devyani ; Srivastava, Shashikant ; Gumbo, Tawanda
International Journal of Antimicrobial Agents.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

It takes two to tango! Stability of drugs affecting efficac..:

Singh, Sanjay ; Srivastava, Shashikant
International Journal of Antimicrobial Agents.  63 (2024)  2 - p. 107060 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Omadacycline drug susceptibility testing for non-tuberculou..:

Boorgula, Gunavanthi D. ; Gumbo, Tawanda ; Singh, Sanjay...
Tuberculosis.  147 (2024)  - p. 102519 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Hollow-fibre system model of tuberculosis reproducibility a..:

Gumbo, Tawanda ; Srivastava, Shashikant ; Deshpande, Devyani...
Journal of Antimicrobial Chemotherapy.  78 (2023)  4 - p. 953-964 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Safety and tolerability of long-term use of omadacycline in..:

Srivastava, Shashikant ; Gumbo, Tawanda
IDCases.  33 (2023)  - p. e01843 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Meropenem-vaborbactam restoration of first-line drug effica..:

Singh, Sanjay ; Gumbo, Tawanda ; Alffenaar, Jan-Willem...
International Journal of Antimicrobial Agents.  62 (2023)  6 - p. 106968 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Editorial: Pharmacology of infectious diseases: world tuber..:

Srivastava, Shashikant ; Alffenaar, Johannes W. ; Wicha, Sebastian G.
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Sarecycline pharmacokinetics/pharmacodynamics in the hollow..:

Singh, Sanjay ; Boorgula, Gunavanthi D ; Aryal, Santosh...
Journal of Antimicrobial Chemotherapy.  79 (2023)  1 - p. 96-99 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Isoniazid pharmacokinetics/pharmacodynamics as monotherapy ..:

Boorgula, Gunavanthi D. ; Singh, Sanjay ; Shankar, Prem...
Tuberculosis.  138 (2023)  - p. 102289 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Comment on "Long-term Safety and Tolerability of Omadacycli..:

Srivastava, Shashikant ; Gumbo, Tawanda
Open Forum Infectious Diseases.  10 (2023)  8 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Omadacycline pharmacokinetics/pharmacodynamics in the hollo..:

Singh, Sanjay ; Wang, Jann-Yuan ; Heysell, Scott K....
International Journal of Antimicrobial Agents.  62 (2023)  1 - p. 106847 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Ceftriaxone Efficacy for Mycobacterium avium Complex Lung D..:

Deshpande, Devyani ; Magombedze, Gesham ; Boorgula, Gunavanthi D...
The Journal of Infectious Diseases.  , 2023
Link: https://doi.org/10.1093/..
 
?
13

Challenges and a potential solution to perform drug suscept..:

Shankar, Prem ; Singh, Sanjay ; Boorgula, Gunavanthi D....
Tuberculosis.  137 (2022)  - p. 102269 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fi..:

Srivastava, Shashikant ; Boorgula, Gunavanthi D. ; Wang, Jann-Yuan...
Antimicrobial Agents and Chemotherapy.  66 (2022)  4 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
15

An overview of drugs for the treatment of Mycobacterium kan..:

Srivastava, Shashikant ; Pasipanodya, Jotam G. ; Heysell, Scott K....
Journal of Global Antimicrobial Resistance.  28 (2022)  - p. 71-77 , 2022
Link: https://doi.org/10.1016/..
 
1-15